piperidine has been researched along with Disease Models, Animal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Gao, L; Hao, C; Jin, J; Liu, BF; Liu, X; Xiong, J; Zhang, G | 1 |
| Ahmad Bhat, M; Al-Omar, MA; Naglah, AM | 1 |
| Barnes, KD; Blaner, WS; Chen, P; Cioffi, CL; Conlon, MP; Freeman, EE; Johnson, G; Kitchen, DB; Martin, WH; Pearson, PG; Petrukhin, K; Racz, B; Varadi, A; Zhu, L | 1 |
| Chiba, K; Fujimoto, T; Inoue, S; Miyazaki, S; Mochizuki, A; Mori, Y; Nagai, Y; Nagayama, T; Nakamura, Y; Nishi, T; Ogawa, Y; Sugita, C; Tamaki, K | 1 |
| Bhosale, VM; Chaudhari, SS; Gudi, GS; Kadam, AB; Karnik, PV; Khairatkar-Joshi, N; Mukhopadhyay, I; Raghuram, A; Rao, SS; Sangana, RR; Thomas, A; Vaiyapuri, TS; Wale, DP | 1 |
| Gogineni, A; Hanson, JE; Herrington, J; Meilandt, WJ; Reynen, P; Scearce-Levie, K; Weimer, RM; Zhou, Q | 1 |
| Beretta, EE; Cameron, KO; Chen, Y; Chu-Moyer, M; Fernando, D; Gao, H; Gautreau, D; Guzman-Perez, A; Hadcock, JR; Hoth, C; Jardine, Pda S; Kohrt, J; Lavergne, S; Makowski, M; Perez, S; Perry, DA; Polivkova, J; Rogers, L; Scott, DO; Swick, AG; Thiede, L; Trebino, CE; Trilles, RV; Wilmowski, J; Zhang, Y | 1 |
| Chen, Y; Liu, BF; Liu, X; Xu, X; Zhang, G | 1 |
| Ahmad, FJ; Ali, MM; Aqil, M; Chowdhary, I; Sultana, Y; Talegaonkar, S | 1 |
| Aritake, K; Hayashi, K; Hayashi, M; Hirotsu, I; Hizue, M; Kimura, Y; Matsushita, N; Mitsui, K; Nakajima, H; Takada, A; Tani, T | 1 |
| Hasegawa, S; Hirota, TK; Komoto, T; Kotake, J; Koya, H; Otsuka, M; Sakamoto, T; Sato, S | 1 |
11 other study(ies) available for piperidine and Disease Models, Animal
| Article | Year |
|---|---|
Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain.
Topics: Amides; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Guinea Pigs; Injections, Subcutaneous; Mice; Mice, Inbred ICR; Molecular Structure; Neuralgia; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Receptors, sigma; Sciatic Nerve; Sigma-1 Receptor; Structure-Activity Relationship | 2020 |
Synthesis and in vivo anti-ulcer evaluation of some novel piperidine linked dihydropyrimidinone derivatives.
Topics: Animals; Anti-Ulcer Agents; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Models, Molecular; Molecular Structure; Piperidines; Pyrimidinones; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship | 2018 |
Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis.
Topics: Animals; Chemistry Techniques, Synthetic; Disease Models, Animal; Drug Design; Fatty Liver; Male; Mice; Piperidines; Rats; Retinol-Binding Proteins, Plasma; Tissue Distribution | 2019 |
Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
Topics: Administration, Oral; Amides; Animals; Blood Pressure; Disease Models, Animal; Furosemide; Half-Life; Hypertension; Macaca fascicularis; Piperazines; Piperidines; Protease Inhibitors; Rats; Rats, Transgenic; Renin; Structure-Activity Relationship | 2013 |
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
Topics: Administration, Oral; Amides; Analgesics; Animals; Disease Models, Animal; Half-Life; Male; Mice; Mice, Inbred C57BL; Neuralgia; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; TRPM Cation Channels | 2013 |
Chronic GluN2B antagonism disrupts behavior in wild-type mice without protecting against synapse loss or memory impairment in Alzheimer's disease mouse models.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Attention Deficit and Disruptive Behavior Disorders; Behavior, Animal; Disease Models, Animal; Female; HEK293 Cells; Humans; In Vitro Techniques; Male; Maze Learning; Membrane Potentials; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Piperidines; Synapses | 2014 |
Discovery of new piperidine amide triazolobenzodiazepinones as intestinal-selective CCK1 receptor agonists.
Topics: Amides; Animals; Cells, Cultured; Disease Models, Animal; Drug Discovery; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Obese; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Structure-Activity Relationship; Weight Loss | 2012 |
Synthesis and evaluation of a series of piperidine-2,6-dione-piperazine (piperidine) derivatives as multireceptor atypical antipsychotics.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Mice; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Histamine H1; Receptors, Serotonin; Structure-Activity Relationship | 2012 |
Transdermal therapeutic system of enalapril maleate using piperidine as penetration enhancer.
Topics: Acrylates; Administration, Cutaneous; Animals; Antihypertensive Agents; Biological Availability; Blood Pressure; Disease Models, Animal; Drug Stability; Drug Storage; Enalapril; Excipients; Female; Hypertension; Male; Permeability; Piperidines; Polymers; Povidone; Rats; Skin Absorption | 2008 |
Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic effects in various experimental models.
Topics: Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Antigens; Bronchoconstriction; Capillary Permeability; Dibenzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity, Delayed; Imidazoles; Ketotifen; Leukocytes; Male; Mice; Mice, Inbred ICR; Nasal Mucosa; Passive Cutaneous Anaphylaxis; Piperidines; Rats; Rats, Wistar; Respiratory Hypersensitivity | 1998 |
New strong fibrates with piperidine moiety.
Topics: Animals; Disease Models, Animal; Hypercholesterolemia; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Piperazine; Piperazines; Piperidines; Propionates; Rats; Rats, Sprague-Dawley | 2000 |